Botulinum Toxin Type A Liquid
NDC Package 0023-1111-99

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Botulinum Toxin Type A liquids is a bulk ingredient utilized for pharmaceutical compounding or manufacturing. This formulation utilizes a liquid delivery system. Marketed by Allergan, Inc., this product is identified by NDC 0023-1111.

Identification & Billing

NDC Package Code
0023-1111-99
Package Description
1 VIAL, GLASS in 1 CYLINDER / 17.5 mg in 1 VIAL, GLASS
Product Code
0023-1111
11-Digit Billing Format
00023111199

Clinical Specifications

Proprietary Name
Botulinum Toxin Type A
Non-Proprietary Name
Botulinum Toxin Type A
Substance Name
Botulinum Toxin Type A
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Active Ingredient(s)

Regulatory & Marketing

Labeler Name
Allergan, Inc.
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
02-29-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0023-1111). Click a package code to view its specific billing and regulatory data.

0023-1111-10
1 VIAL, GLASS in 1 CYLINDER / 17.5 mg in 1 VIAL, GLASS

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0023-1111-99 identifies a specific commercial package of 1 vial, glass in 1 cylinder / 17.5 mg in 1 vial, glass of Botulinum Toxin Type A (UNFINISHED drug), a bulk ingredient labeled by Allergan, Inc.. This liquid is formulated for use and contains botulinum toxin type a as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Allergan, Inc. on February 29, 2024. The current certification is valid through December 31, 2026.

How is this Allergan, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00023111199. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0023-1111-99
11-Digit CMS (5-4-2)
00023-1111-99

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.